Article
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jun 2026
Lanino Luca, Hunter Anthony M, Gagelmann Nico, Robin Marie, Dall'Olio Daniele, Flamigni Alice, Sala Claudia, Gurnari Carmelo, Wang Yu-Hung, Pleyer Lisa, Xicoy Blanca, Montalban-Bravo Guillermo, Shih Lee-Yung, Alsugair Ali, Fathima Saubia, Gregorio Caterina, Rollo Cesare, Palomo Laura, Platzbecker Anne Sophie, Asti Gianluca, Itzykson Raphael, Sallman David A, Fariselli Piero, Kern Wolfgang, Garcia-Manero Guillermo, Platzbecker Uwe, Solé Francesc, Diez-Campelo Maria, Maciejewski Jaroslaw, Bejar Rafael, Thol Felicitas, Kroger Nicolaus, Savona Michael, Fenaux Pierre, Sanz Guillermo, Kordasti Shahram, Santini Valeria, Fontenay Michaela, Zeidan Amer M, Komrokji Rami S, Haferlach Torsten, Germing Ulrich, Castellani Gastone, D'Amico Saverio, Patnaik Mrinal, Ieva Francesca, Solary Eric, Tefferi Ayalew, Padron Eric, Della Porta Matteo Giovanni
Abstract excerpt
PURPOSE: Chronic myelomonocytic leukemia (CMML) is a rare myeloid neoplasm characterized by clinical heterogeneity and is associated with poor outcomes. To date, limited molecular information has been incorporated into disease classification and risk stratification. We aimed to integrate genomic features into the clinical decision-making process for CMML. PATIENTS AND METHODS: We analyzed a retrospective cohort...
Read the complete abstract on PubMed